Latest filing published 22 Feb 2016 for Valeant Pharmaceuticals International, Inc., €6.0M.
No signal scores available.
Howard Schiller is a declared insider of Valeant Pharmaceuticals International, Inc., with filings sourced from SEDI. We count 4 filings, every one of them for a trade on 18 February 2016.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 22 February 2016: an option exercise of €6.0M, in Valeant Pharmaceuticals International, Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations